CY1110975T1 - Κρυσταλλος ενωσεως ινδολης περιεχουσης σουλφοναμιδιο και μεθοδος παραγωγης του - Google Patents

Κρυσταλλος ενωσεως ινδολης περιεχουσης σουλφοναμιδιο και μεθοδος παραγωγης του

Info

Publication number
CY1110975T1
CY1110975T1 CY20101101136T CY101101136T CY1110975T1 CY 1110975 T1 CY1110975 T1 CY 1110975T1 CY 20101101136 T CY20101101136 T CY 20101101136T CY 101101136 T CY101101136 T CY 101101136T CY 1110975 T1 CY1110975 T1 CY 1110975T1
Authority
CY
Cyprus
Prior art keywords
crystall
united
industry
production
sulfonamide
Prior art date
Application number
CY20101101136T
Other languages
Greek (el)
English (en)
Inventor
Keiko Takahashi
Kenji Hayashi
Taichi Abe
Takao Omae
Takashi Kato
Original Assignee
Eisai R&D Management Co., Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Management Co., Ltd filed Critical Eisai R&D Management Co., Ltd
Publication of CY1110975T1 publication Critical patent/CY1110975T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CY20101101136T 2003-09-10 2010-12-10 Κρυσταλλος ενωσεως ινδολης περιεχουσης σουλφοναμιδιο και μεθοδος παραγωγης του CY1110975T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003318953 2003-09-10
EP04772605A EP1666463B1 (en) 2003-09-10 2004-09-01 Crystal of sulfonamide-containing indole compound and process for producing the same

Publications (1)

Publication Number Publication Date
CY1110975T1 true CY1110975T1 (el) 2015-06-11

Family

ID=34308544

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101101136T CY1110975T1 (el) 2003-09-10 2010-12-10 Κρυσταλλος ενωσεως ινδολης περιεχουσης σουλφοναμιδιο και μεθοδος παραγωγης του

Country Status (24)

Country Link
US (2) US7754894B2 (https=)
EP (1) EP1666463B1 (https=)
JP (1) JP4435090B2 (https=)
KR (1) KR20060120644A (https=)
CN (2) CN101165049A (https=)
AT (1) ATE486849T1 (https=)
AU (1) AU2004272400B2 (https=)
BR (1) BRPI0414314A (https=)
CA (1) CA2536995C (https=)
CY (1) CY1110975T1 (https=)
DE (1) DE602004029907D1 (https=)
DK (1) DK1666463T3 (https=)
ES (1) ES2354286T3 (https=)
HR (1) HRP20100631T1 (https=)
IL (2) IL174059A0 (https=)
MX (1) MXPA06002732A (https=)
NO (1) NO335256B1 (https=)
NZ (1) NZ546111A (https=)
PL (1) PL1666463T3 (https=)
PT (1) PT1666463E (https=)
RU (1) RU2336269C2 (https=)
SI (1) SI1666463T1 (https=)
TW (1) TW200514770A (https=)
WO (1) WO2005026118A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1666463T3 (da) * 2003-09-10 2010-12-20 Eisai R&D Man Co Ltd Krystal af sulfonamidholdig indolforbindelse og fremgangsmåde til fremstilling deraf

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3868534B2 (ja) 1996-05-24 2007-01-17 エーザイ・アール・アンド・ディー・マネジメント株式会社 スルホンアミド誘導体の製造法および中間体
JP2000247949A (ja) 1999-02-26 2000-09-12 Eisai Co Ltd スルホンアミド含有インドール化合物
WO2001056607A1 (en) * 2000-02-03 2001-08-09 Eisai Co., Ltd. Integrin expression inhibitors
TWI283575B (en) * 2000-10-31 2007-07-11 Eisai Co Ltd Medicinal compositions for concomitant use as anticancer agent
DK1666463T3 (da) * 2003-09-10 2010-12-20 Eisai R&D Man Co Ltd Krystal af sulfonamidholdig indolforbindelse og fremgangsmåde til fremstilling deraf

Also Published As

Publication number Publication date
EP1666463A4 (en) 2007-12-12
NO20061545L (no) 2006-06-09
PL1666463T3 (pl) 2011-04-29
WO2005026118A1 (ja) 2005-03-24
NZ546111A (en) 2008-11-28
BRPI0414314A (pt) 2006-10-31
MXPA06002732A (es) 2006-06-05
AU2004272400A1 (en) 2005-03-24
SI1666463T1 (sl) 2011-02-28
TW200514770A (en) 2005-05-01
IL196569A0 (en) 2011-07-31
US7754894B2 (en) 2010-07-13
RU2006111454A (ru) 2006-08-27
CN1849305A (zh) 2006-10-18
PT1666463E (pt) 2011-01-17
HK1092796A1 (en) 2007-02-16
CA2536995C (en) 2013-12-17
CN100406440C (zh) 2008-07-30
IL174059A0 (en) 2006-08-01
ATE486849T1 (de) 2010-11-15
AU2004272400B2 (en) 2010-03-04
DE602004029907D1 (de) 2010-12-16
CN101165049A (zh) 2008-04-23
KR20060120644A (ko) 2006-11-27
TWI349663B (https=) 2011-10-01
ES2354286T3 (es) 2011-03-11
US20070082941A1 (en) 2007-04-12
CA2536995A1 (en) 2005-03-24
EP1666463B1 (en) 2010-11-03
HRP20100631T1 (hr) 2010-12-31
DK1666463T3 (da) 2010-12-20
JPWO2005026118A1 (ja) 2007-11-08
EP1666463A1 (en) 2006-06-07
NO335256B1 (no) 2014-10-27
US20090247768A1 (en) 2009-10-01
RU2336269C2 (ru) 2008-10-20
JP4435090B2 (ja) 2010-03-17

Similar Documents

Publication Publication Date Title
CY1106425T1 (el) Ενωσις βενζυλαμινης και φαρμακευτικη χρησις αυτης
CY2012005I1 (el) Συνθεσεις και μεθοδοι για σταθεροποιηση τρανσθυρετινης και παρεμποδιση εσφαλμενης αναδιπλωσης τρανσθυρετινης
CY2016013I1 (el) Φαρμακευτικες συνθεσεις που περιλαμβανουν βαλσαρτανη και αναστολεις nep
MY154538A (en) Imprint lithography templates having alignment marks
PL375021A1 (en) Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes
FR2853631B1 (fr) Materiau d'emballage et procede pour sa production
CY1109068T1 (el) Υποκατεστημενες πυριδινυλαμινες
CY1114351T1 (el) Παραγωγα ν-φαινυλ-2-πυριμιδινης-αμινης
DE60206439D1 (de) Mehrschichtmaterial zum Verpacken von Kaugummis
DE602005027126D1 (de) Schmales zahnimplantat und zugeordnete teile
PL372996A1 (en) 3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl)-n-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition
CY1115162T1 (el) Νεα μεθοδος βιομηχανικης συνθεσης του ρανελικου στροντιου και των ενυδρων αλατων του
CY1110537T1 (el) Ενωσεις και μεθοδοι για την αγωγη της δυσλιπιδαιμιας
DE602004019795D1 (de) Kombination aus n-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-ä1,3,4-oxadiazol-2-ylüphenyl)pyridin-3-sulfonamid und einem biphosphonat
EP1666524A4 (en) Perfluoroelastomer SEAL MATERIAL
CY1110975T1 (el) Κρυσταλλος ενωσεως ινδολης περιεχουσης σουλφοναμιδιο και μεθοδος παραγωγης του
ATE458465T1 (de) Kosmetische und/oder dermatologische zusammensetzung mit bornitrid
DE60228183D1 (de) Fotopolymerisierbare Zusammensetzung und Aufzeichnungsmaterial
ATE387100T1 (de) Calciumsalz enthaltender kaugummi
DE60301490D1 (de) Röntgenopakes und aseptisches Material zum Abdrucknehmen zur Verwendung in Implantodontika
MXPA04000954A (es) 3,5-dibidroxi-2,2-dimetil-valeroamidas protegidas para la sintesis de epotilonas y derivados, un procedimiento para su preparacion y el empleo de las mismas.
ATE461174T1 (de) Neue piperidinderivate und deren verwendung als monoaminneurotransmitter-wiederaufnahmehemmer
PL379628A1 (pl) Nowy sposób syntezy perindoprilu i jego farmaceutycznie dopuszczalnych soli
DE50309337D1 (de) Calcium enthaltende süssigkeit
ITUD20020105A0 (it) Apparecchiatura e metodo per vagliare materiali aventi differenti dimensioni e/o densita'